Literature DB >> 23975412

Association of trisomy 18 with hepatoblastoma and its implications.

Zhen Han Tan1, Angeline Lai, Ching Kit Chen, Kenneth T E Chang, Ah Moy Tan.   

Abstract

UNLABELLED: Hepatoblastoma is a highly malignant embryonal liver tumor that occurs almost exclusively in infants and toddlers. Trisomy 18 is the second most common autosomal trisomy after trisomy 21 and is generally considered a lethal disorder. Ten cases of hepatoblastoma in children with trisomy 18 have been published to date. Here, we report on two female patients with trisomy 18 and pretreatment extent of disease (PRETEXT) stage 1 hepatoblastoma, which support the presence of a nonrandom association between hepatoblastoma and trisomy 18. Both patients underwent primary surgical resection without any neoadjuvant or adjuvant chemotherapy. The histologies returned as pure fetal epithelial type, and combined fetal and embryonal epithelial type. There was no evidence of recurrence on serial abdominal ultrasound and serum alpha-fetoprotein levels on follow-up.
CONCLUSION: Primary surgical resection is a treatment approach that can be considered in children with trisomy 18 and PRETEXT stage 1 tumor. However, in view of the overall prognosis for trisomy 18, the decision on the optimal treatment is a delicate one and has to be individualized in the context of the best interests of the child.

Entities:  

Mesh:

Year:  2013        PMID: 23975412     DOI: 10.1007/s00431-013-2147-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Successful treatment for hepatoblastoma in a 1-year-old boy with trisomy 18.

Authors:  Shota Uekusa; Kiminobu Sugito; Hiroyuki Kawashima; Shinsuke Yoshizawa; Takeshi Furuya; Kensuke Ohashi; Taro Ikeda; Tsugumichi Koshinaga; Hideo Mugishima
Journal:  Pediatr Int       Date:  2012-06       Impact factor: 1.524

2.  Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic.

Authors:  Melanie P McGraw; Jeffrey M Perlman
Journal:  Pediatrics       Date:  2008-06       Impact factor: 7.124

3.  Population-based analyses of mortality in trisomy 13 and trisomy 18.

Authors:  Sonja A Rasmussen; Lee-Yang C Wong; Quanhe Yang; Kristin M May; J M Friedman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

Review 4.  Hepatoblastoma: recent developments in research and treatment.

Authors:  Dietrich von Schweinitz
Journal:  Semin Pediatr Surg       Date:  2012-02       Impact factor: 2.754

5.  The experience of families with children with trisomy 13 and 18 in social networks.

Authors:  Annie Janvier; Barbara Farlow; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

6.  Trisomy 18 in a 20-year-old woman.

Authors:  Michael Kelly; Bradley W Robinson; John W Moore
Journal:  Am J Med Genet       Date:  2002-11-01

Review 7.  Hepatoblastoma in a mosaic trisomy 18 patient.

Authors:  Elaine Maria Pereira; Robert Marion; K H Ramesh; Jane S Kim; Michelle Ewart; Rosanna Ricafort
Journal:  J Pediatr Hematol Oncol       Date:  2012-05       Impact factor: 1.289

8.  The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan.

Authors:  Jun Maeda; Hiroyuki Yamagishi; Yoshiyuki Furutani; Mitsuhiro Kamisago; Tadashi Waragai; Shinji Oana; Hiroki Kajino; Hiroyuki Matsuura; Katsuhiko Mori; Rumiko Matsuoka; Toshio Nakanishi
Journal:  Am J Med Genet A       Date:  2011-10-11       Impact factor: 2.802

9.  Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism.

Authors:  A Koufos; M F Hansen; N G Copeland; N A Jenkins; B C Lampkin; W K Cavenee
Journal:  Nature       Date:  1985 Jul 25-31       Impact factor: 49.962

10.  Neonatal management of trisomy 18: clinical details of 24 patients receiving intensive treatment.

Authors:  Tomoki Kosho; Tomohiko Nakamura; Hiroshi Kawame; Atsushi Baba; Masanori Tamura; Yoshimitsu Fukushima
Journal:  Am J Med Genet A       Date:  2006-05-01       Impact factor: 2.802

  10 in total
  6 in total

1.  Advances in the treatment of pediatric solid tumors: A 50-year perspective.

Authors:  Michael P LaQuaglia; Justin T Gerstle
Journal:  J Surg Oncol       Date:  2022-10       Impact factor: 2.885

2.  Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Authors:  Rajkumar Venkatramani; Logan G Spector; Michael Georgieff; Gail Tomlinson; Mark Krailo; Marcio Malogolowkin; Wendy Kohlmann; Karen Curtin; Rachel K Fonstad; Joshua D Schiffman
Journal:  Am J Med Genet A       Date:  2014-06-16       Impact factor: 2.802

3.  Hepatoblastoma Associated with Trisomy 18.

Authors:  Leonardo I Valentin; Luis Perez; Prakash Masand
Journal:  J Pediatr Genet       Date:  2015-10-19

4.  Hepatoblastoma in a mosaic trisomy 18 child with hemihypertrophy.

Authors:  Naveed Ahmad; Kate Wheeler; Helen Stewart; Carolyn Campbell
Journal:  BMJ Case Rep       Date:  2016-01-21

5.  First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction.

Authors:  Bartosz Czuba; Piotr Tousty; Wojciech Cnota; Dariusz Borowski; Agnieszka Jagielska; Mariusz Dubiel; Anna Fuchs; Magda Fraszczyk-Tousty; Sylwia Dzidek; Anna Kajdy; Grzegorz Świercz; Sebastian Kwiatkowski
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

6.  A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.

Authors:  Tian Zhi; Wei-Ling Zhang; Yi Zhang; Hui-Min Hu; Yi-Zhuo Wang; Dong-Sheng Huang
Journal:  BMC Cancer       Date:  2021-04-13       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.